Tag: Hudson Institute of Medical Research
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Featured Article
How Taiwan is revolutionising its AI data centres with liquid cooling
The rapid advancement of artificial intelligence relies heavily on the infrastructure that supports it. As AI continues to transform industries worldwide, the demand for robust and efficient data centre operations has never been more critical. This, in turn, has brought attention to the environmental impact of these facilities.
